Reproducible and Quality Data for Harnessing AI-enhanced Digital Pathology to Develop Companion Diagnostics to Enhance Drug Response Rate

Time: 2:30 pm
day: Day Two


  • How is AI harnessing pathological data for the identification of novel biomarkers to accurately predict drug response rate?
  • How can different algorithms permit accurate patient selection based on pathological data to determine responders versus non-responders?
  • How can multiple data sources be accurately validated to ensure accurate Companion Diagnostics generation?